Management of patients with status epilepticus treated at a pediatric intensive care unit in Turkey

Pediatr Neurol. 2012 Jun;46(6):382-6. doi: 10.1016/j.pediatrneurol.2012.03.013.

Abstract

We investigated the etiology, treatment, and prognosis of patients treated for status epilepticus at a pediatric intensive care unit. Medical records of 89 patients admitted to a pediatric intensive care unit with status epilepticus were reviewed retrospectively. Patients ranged in age from 2 months to 18 years (mean age ± S.D., 4.7 ± 3.8 years). Seizure etiologies comprised remote symptomatic in 47 (52.7%), febrile in 15 (16.9%), acute symptomatic in 12 (13.5%), and unknown in 15 (16.9%). Seizure durations ranged from 30-60 minutes in 58 patients, whereas 31 manifested refractory seizures longer than 60 minutes. Seizure control was achieved within 30 minutes in 55 patients, from 30-60 minutes in 19, and after 60 minutes in 15. Rectal diazepam was administered to 38 (42.7%) patients before admission to the hospital. Length of intensive care unit stay increased with increasing seizure duration (P < 0.05). The total mortality rate was 3.4%. This lower mortality rate may be considered evidence of the effectiveness and reliability of the status epilepticus treatment protocol in our pediatric intensive care unit. Prehospital rectal diazepam administration and the treatment of brain edema in the intensive care unit may be useful in the management of patients with status epilepticus.

MeSH terms

  • Adolescent
  • Child
  • Disease Management
  • Female
  • Humans
  • Infant
  • Intensive Care Units, Pediatric* / trends
  • Male
  • Retrospective Studies
  • Status Epilepticus / diagnosis
  • Status Epilepticus / epidemiology*
  • Status Epilepticus / therapy*
  • Treatment Outcome
  • Turkey / epidemiology